Physician profile
Manish Patel
NPI 1255688255
$54,434.07
in general payments reported to CMS, 2019-2025
27 companies · $349 in 2025
The $349 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $377 · 2020: $78.83 · 2021: $113 · 2022: $46K · 2023: $5,704 · 2024: $1,812 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $6,194 · Food and Beverage: $1,143 · Education: $528.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $6,193.84 |
| Food and Beverage | $1,143.16 |
| Education | $528.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $52,203.46 | 2020-2024 | Avenger Radial Head, +4 Stems |
| Djo, LLC | $528.00 | 2023 | Dr Comfort |
| Reddress USA, INC. | $460.64 | 2024 | |
| Stryker Corporation | $265.74 | 2019 | |
| Abbott Laboratories | $141.56 | 2023 | Proclaim, Eon C, Eterna |
| Melinta Therapeutics, LLC | $83.61 | 2019 | |
| Paratek Pharmaceuticals, INC. | $68.78 | 2025 | Nuzyra |
| Medtronic, INC. | $66.28 | 2021 | |
| Amgen INC. | $65.51 | 2025 | Krystexxa |
| Ani Pharmaceuticals, INC. | $61.75 | 2025 | Purified Cortrophin Gel |
| Restor3d, INC. | $46.98 | 2025 | |
| Grt US Holding, INC. | $46.71 | 2021 | |
| Globus Medical, INC. | $45.60 | 2024 | Distal Tibia Plating, External Fixation, Ankle Fracture System |
| Trilliant Surgical LLC. | $44.03 | 2024 | Arsenal Ankle 10 Hole 1/3 Tubular Plate |
| Smith+Nephew, INC. | $43.79 | 2020-2025 | Stravix Pl |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trimed, INC. | $39.15 | 2025 | |
| Coloplast Corp | $27.54 | 2024 | |
| Medinc of Texas | $25.90 | 2024 | |
| Kyowa Kirin, INC. | $25.88 | 2025 | |
| Wright Medical Technology, INC. | $25.42 | 2020 | |
| Bioventus LLC | $24.54 | 2025 | Exogen Ultrasound Bone Healing System |
| Ibsa Pharma INC. | $17.93 | 2023 | Tirosint, Licart |
| Zimmer Biomet Holdings, INC. | $17.08 | 2019 | |
| Ermi LLC | $16.64 | 2024 | |
| Arbor Pharmaceuticals, INC. | $16.28 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.29 | 2023 | Seglentis |
| Merck Sharp & Dohme LLC | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manish Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.